Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma

The diagnosis of early stage cutaneous T-cell lymphoma is often difficult, particularly in mycosis fungoides (MF), because the clinical presentation, histological findings, and laboratory findings of MF resemble those of inflammatory skin diseases such as atopic dermatitis, psoriasis, and parapsoria...

Full description

Bibliographic Details
Main Authors: Kazuyasu Fujii, Takuro Kanekura
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2019.00181/full
id doaj-0376938506774f249e01647d3f1f88be
record_format Article
spelling doaj-0376938506774f249e01647d3f1f88be2020-11-25T01:32:32ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2019-08-01610.3389/fmed.2019.00181480956Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell LymphomaKazuyasu FujiiTakuro KanekuraThe diagnosis of early stage cutaneous T-cell lymphoma is often difficult, particularly in mycosis fungoides (MF), because the clinical presentation, histological findings, and laboratory findings of MF resemble those of inflammatory skin diseases such as atopic dermatitis, psoriasis, and parapsoriasis en plaque. Furthermore, MF sometimes occurs with or after these inflammatory skin diseases. The current diagnostic criteria heavily rely on clinical impressions along with assessments of T cell clonality. To make a diagnosis of early-stage MF, the detection of a malignant clone is critical. T cell receptor (TCR) gene rearrangements have been detected by southern blotting or polymerase chain reaction for this purpose, but the results of these methods are insufficient. High-throughput TCR sequencing has provided insights into the complexities of the immune repertoire. Accordingly, his technique is more sensitive and specific than current methods, making it useful for the detection of early lesions and monitoring responses to therapy.https://www.frontiersin.org/article/10.3389/fmed.2019.00181/fullmycosis fungoidesearly stageT-cell receptorrearrangementnext-generation sequencing
collection DOAJ
language English
format Article
sources DOAJ
author Kazuyasu Fujii
Takuro Kanekura
spellingShingle Kazuyasu Fujii
Takuro Kanekura
Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma
Frontiers in Medicine
mycosis fungoides
early stage
T-cell receptor
rearrangement
next-generation sequencing
author_facet Kazuyasu Fujii
Takuro Kanekura
author_sort Kazuyasu Fujii
title Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma
title_short Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma
title_full Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma
title_fullStr Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma
title_full_unstemmed Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma
title_sort next-generation sequencing technologies for early-stage cutaneous t-cell lymphoma
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2019-08-01
description The diagnosis of early stage cutaneous T-cell lymphoma is often difficult, particularly in mycosis fungoides (MF), because the clinical presentation, histological findings, and laboratory findings of MF resemble those of inflammatory skin diseases such as atopic dermatitis, psoriasis, and parapsoriasis en plaque. Furthermore, MF sometimes occurs with or after these inflammatory skin diseases. The current diagnostic criteria heavily rely on clinical impressions along with assessments of T cell clonality. To make a diagnosis of early-stage MF, the detection of a malignant clone is critical. T cell receptor (TCR) gene rearrangements have been detected by southern blotting or polymerase chain reaction for this purpose, but the results of these methods are insufficient. High-throughput TCR sequencing has provided insights into the complexities of the immune repertoire. Accordingly, his technique is more sensitive and specific than current methods, making it useful for the detection of early lesions and monitoring responses to therapy.
topic mycosis fungoides
early stage
T-cell receptor
rearrangement
next-generation sequencing
url https://www.frontiersin.org/article/10.3389/fmed.2019.00181/full
work_keys_str_mv AT kazuyasufujii nextgenerationsequencingtechnologiesforearlystagecutaneoustcelllymphoma
AT takurokanekura nextgenerationsequencingtechnologiesforearlystagecutaneoustcelllymphoma
_version_ 1725081435478425600